US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
NASDAQ
Creative Medical Technology Holdings Inc (CELZ)
Creative Medical Technology Holdings Inc (CELZ) ニュース

Creative Medical Technology Holdings Inc (CELZ)

2.06

-0.06

(-2.83%)

終了 6月7日 5:00AM

2.10

0.04

(1.94%)

取引時間後: 6:48AM

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Creative Medical Technology Holdings, Inc. Reports Breakthrough 93% Response Rate in Ultrasome™ Knee Osteoarthritis Program, Expanding CELZ-201 Platform into Scalable Cell-Free Regenerative Therapies

Ultrasome™ Demonstrates Strong Clinical Signal While Leveraging GMP-Produced CELZ-201 (Olastrocel) to Target...

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Creative Medical Technology Holdings Achieves Second WHO INN Milestone, Strengthening Global Regulatory Positioning Across Expanding Cell Therapy Pipeline

PHOENIX, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ...

Creative Medical Technology Holdings Reaches Major Clinical Inflection Point with Positive Interim Data from ADAPT Trial and CELZ-201 (Olastrocel) in the Treatment of Chronic Lower Back Pain

PHOENIX, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ...

Creative Medical Technology Holdings Receives Regulatory Approval for BioDefense Burn Pit Initiative

PHOENIX, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ...

Form 8-K - Current report

Form 8-K - Current report

Creative Medical Technology Holdings, Inc. Completes Enrollment in FDA-Cleared ADAPT Trial for CELZ-201-Olastrocel, Marking Major Clinical Inflection Point

PHOENIX, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a...

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form EFFECT - Notice of Effectiveness

Creative Medical Technology Holdings Announces World Health Organization Approval of “olastrocel” as INN for Lead Allogeneic Cell Therapy CELZ-201

PHOENIX, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ...

Form S-3 - Registration statement under Securities Act of 1933

Form DEF 14A - Other definitive proxy statements

Mr79

https://clinicaltrials.gov/study/NCT06053242?spons=Creative%20Medical%20Technology%20Holdings%20Inc&rank=1

Mr79

Mr79

Mr79

https://www.quiverquant.com/news/Creative+Medical+Technology+Holdings%2C+Inc.+Reports+Positive+Interim+Results+from+CELZ-201+Clinical+Trial+for+Chronic+Lower+Back+Pain

Mr79

👍️ 1 🤞 1

SmellMyFinger

SmellMyFinger 7月前

This was mentioned in today's news regarding the $4.2 million in warrants for $CELZ...

"In consideration for the immediate exercise of the existing warrants for cash, the Company will issue new unregistered warrants to purchase shares of common stock. The new warrants will be exercisable for an aggregate of up to 2,790,340 shares of common stock, at an exercise price of $3.75 per share..."

Seems dilutive, both now and in the future. I'm curious how others perceive this.

TOM611

TOM611 11月前

Go. Celz. Heart. Stroke. Patent. We Gonna be. Huge.

SmellMyFinger

SmellMyFinger 11月前

It went up a dollar or so (to $4.28) near the end of the regular trading session, but as of this post is getting beaten back down to below $3 like usual.

BurgerKing82

BurgerKing82 11月前

Did it just jump in after hours...Highest volume in 12-14 monthes

SmellMyFinger

SmellMyFinger 11月前

Thanks for the information. I'll check them out.

UndervaludeOpportunity

UndervaludeOpportunity 11月前

Actually, CELZ does have some revenue, but it’s still very early-stage and mostly R&D-focused. Their core pipeline is still in the clinical/preclinical phase, and the bulk of the story is based on future IP/licensing potential — not commercial operations yet.

If you’re looking for regenerative medicine plays that are already treating patients and generating real revenue, you might want to check out $RMTG.

They’ve got 26 clinics across 21 countries, are already profitable, and specialize in stem cell and peptide therapies being administered now — not 3 years from now.

I follow both, but they’re in completely different stages of development

UndervaludeOpportunity

UndervaludeOpportunity 11月前

$RMTG – 26 Clinics and Profitable, Yet Still Under the Radar?

Saw some familiar themes here and had to mention $RMTG.
They’ve already built 26 clinics across 21 countries focused on regenerative and peptide therapies — and they’re posting real revenue + profitable quarters. 70% YoY growth.

Feels like one of those sleepers that no one’s watching… yet.
If you’re into stem cells, longevity clinics, or real-world medtech, take a look.

SmellMyFinger

SmellMyFinger 1年前

$CELZ, over $2.

Monksdream

Monksdream 1年前

Muhbruh

Muhbruh 1年前

https://www.fda.gov/news-events/press-announcements/fda-announces-plan-phase-out-animal-testing-requirement-monoclonal-antibodies-and-other-drugs

SmellMyFinger

SmellMyFinger 1年前

Is this company still not generating any revenue?

SmellMyFinger

SmellMyFinger 1年前

What else can you say about that?

Kenneth Howell

Kenneth Howell 1年前

Is Tom scamluchy still in this garage. Be careful I was in this crap in 2019 .

👉️ 1 👍️ 1

SmellMyFinger

SmellMyFinger 1年前

$CELZ above $4+.

Monksdream

Monksdream 1年前

SmellMyFinger

SmellMyFinger 1年前

Could take a while for this to hit my average.

Invest-in-America

Invest-in-America 2年前

CELZ: Heck, maybe some SALSA, & then take the SELTZER!! (I'm gettin' CONFUSED!!)

tw0122

Perhaps Alka Celzer time pop pop oh what a relief it is $3.90 + 14% low floater can go wild if foreign hedgies comply

Monksdream

Monksdream 2年前

SmellMyFinger

SmellMyFinger 2年前

Do you mean that another reverse/split is planned for the future? Not likely unless this gets shorted back down to below listing standards ($1).

Harbor6460

Harbor6460 2年前

Just saw a ad on cnbc. Lol. Thought this scam was long dead. I just looked. A RS. Lol. Who knows when it happen?

SmellMyFinger

SmellMyFinger 2年前

Still watching and waiting for this one.

Awl416

SmellMyFinger

SmellMyFinger 2年前

PPS hasn't been here since 2022.

Monksdream

Monksdream 2年前

CELZ new 52 week low

SmellMyFinger

SmellMyFinger 2年前

A little thin on volume lately.

Monksdream

Monksdream 2年前

Invest-in-America

Invest-in-America 2年前

CELZ: Whelp, this CELZ puppy needed some SELTZER to add more 'SPARKLE' to its descending PRICE.

Pt3

Lucky my sell order didn't filled @ 4

trendzone

trendzone 2年前

Want to thank every scared tard who sold to me in yesterday's after hours at below $ 4.65, you guys are the best.

Awl416

Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access

SmellMyFinger

SmellMyFinger 2年前

Awl416

Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy

SmellMyFinger

SmellMyFinger 2年前

Sister company?

SmellMyFinger

SmellMyFinger 3年前

Could it be about time for a pop?

SmellMyFinger

SmellMyFinger 3年前

It certainly could. Many have heavier bags.

centsability4me

centsability4me 3年前

your sister company is doing fine also .

europtiger

europtiger 3年前

You be fine… will pop out of the blue.

centsability4me

centsability4me 3年前

Go CELZ , and T$0* !

centsability4me

centsability4me 3年前

centsability4me

centsability4me 3年前

Pt3

Chased now bag 7+

Awl416

TOM611

Go. Celz. Happy days are here again.

gint1

Laughing, good times come to a end.

Creative Medical Technol...

Broedrene Hartmann A/s

Bryah Resources

Tsubota Laboratory

Dial Square Investments

Atlantic Sapphire ASA

Harvest Oil and Gas (EM)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。